High-dose omalizumab use in patients with chronic spontaneous urticaria

被引：21
作者：
Aghdam, Mehran Alizadeh [1 ]
van den Broek, Fenne [1 ]
Rijken, Feiko [1 ]
Knulst, Andre Cornelis [1 ]
Rockmann, Heike [1 ]
机构：
[1] Univ Utrecht, Univ Med Ctr Utrecht, Dept Dermatol Allergol, Utrecht, Netherlands
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2020年 / 8卷 / 04期
关键词：
MINIMAL IMPORTANT DIFFERENCE; EXPERIENCE;
D O I：
10.1016/j.jaip.2019.10.018
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1426 / +
页数：3
相关论文
共 9 条
  • [1] Omalizumab in chronic spontaneous urticaria A real-life experience of dose and intervals adjustments in Belgium
    de Montjoye, Laurence
    Herman, Anne
    Dumoutier, Laure
    Lambert, Michel
    Tromme, Isabelle
    Baeck, Marie
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : 620 - 622
  • [2] The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update
    Holgate, Stephen
    Buhl, Roland
    Bousquet, Jean
    Smith, Nicola
    Panahloo, Zoya
    Jimenez, Pablo
    [J]. RESPIRATORY MEDICINE, 2009, 103 (08) : 1098 - 1113
  • [3] Knulst AC, 2015, NEDERLANDSE VERENIGI, P1
  • [4] Omalizumab Updosing for Better Disease Control in Chronic Spontaneous Urticaria Patients
    Kocaturk, Emek
    Deza, Gustavo
    Kiziltac, Kubra
    Gimenez-Arnau, Ana M.
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2018, 177 (04) : 360 - 364
  • [5] The minimal important difference for measures of urticaria disease activity: Updated findings
    Mathias, Susan D.
    Crosby, Ross D.
    Rosen, Karin E.
    Zazzali, James L.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2015, 36 (05) : 394 - 398
  • [6] Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria
    Niemeyer-van der Kolk, Tessa
    van Maaren, Maurits S.
    van Doorn, Martijn B. A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (06) : 1992 - 1994
  • [7] Responsiveness and minimal important difference of the urticaria control test
    Ohanyan, Tatevik
    Schoepke, Nicole
    Bolukbasi, Bediha
    Metz, Martin
    Hawro, Tomasz
    Zuberbier, Torsten
    Peveling-Oberhag, Adriane
    Staubach, Petra
    Maurer, Marcus
    Weller, Karsten
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 140 (06) : 1710 - +
  • [8] Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
    Weller, Karsten
    Groffik, Adriane
    Church, Martin K.
    Hawro, Tomasz
    Krause, Karoline
    Metz, Martin
    Martus, Peter
    Casale, Thomas B.
    Staubach, Petra
    Maurer, Marcus
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (05) : 1365 - U604
  • [9] The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
    Zuberbier, T.
    Aberer, W.
    Asero, R.
    Latiff, A. H. Abdul
    Baker, D.
    Ballmer-Weber, B.
    Bernstein, J. A.
    Bindslev-Jensen, C.
    Brzoza, Z.
    Buense Bedrikow, R.
    Canonica, G. W.
    Church, M. K.
    Craig, T.
    Danilycheva, I. V.
    Dressler, C.
    Ensina, L. F.
    Gimenez-Arnau, A.
    Godse, K.
    Goncalo, M.
    Grattan, C.
    Hebert, J.
    Hide, M.
    Kaplan, A.
    Kapp, A.
    Katelaris, C. H.
    Kocaturk, E.
    Kulthanan, K.
    Larenas-Linnemann, D.
    Leslie, T. A.
    Magerl, M.
    Mathelier-Fusade, P.
    Meshkova, R. Y.
    Metz, M.
    Nast, A.
    Nettis, E.
    Oude-Elberink, H.
    Rosumeck, S.
    Saini, S. S.
    Sanchez-Borges, M.
    Schmid-Grendelmeier, P.
    Staubach, P.
    Sussman, G.
    Toubi, E.
    Vena, G. A.
    Vestergaard, C.
    Wedi, B.
    Werner, R. N.
    Zhao, Z.
    Maurer, M.
    [J]. ALLERGY, 2018, 73 (07) : 1393 - 1414
1